Genetics of Angiotensin I-Converting Enzyme

References

• Skeggs L T, Kahn J R, Shumway N P. The preparation and function of the of the hypertensin converting enzyme. J Exp Med 1956; 103: 295–9
   PubMed Web of Science ®Google Scholar
• Erdös E. Angiotensin I- converting enzyme and the changes in our concept through the years. Hypertension (Dallas) 1991; 16: 363–70
   Web of Science ®Google Scholar
• Jaspard E, Wei L, Alhenc-Gelas F. Differences in properties and enzymatic specificities between two active sites of angiotensin I converting-enzyme. J. Biol. Chem. 1993; 268: 9496–9503
   PubMed Web of Science ®Google Scholar
• Azizi M, Rousseau A, Elan E, Guyenne T T, Michelet S, Grognet J M, Lenfant M, Corvol P, Menad J. Acute ACE inhibition increases the plasma level of the natural stem cell regulator N acetyl-seryl-asparty-lysyl-proline. J. Clin. Invest. 1996; 97: 588–592
   PubMedGoogle Scholar
• Cushman D W, Ondetti M A. Inhibitors of angiotensin-converting enzyme. Prog. Med. Chem. 1980; 17: 42–104
   Google Scholar
• Marre M, Chatellier G, Leblanc H, Guyenne T T, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics subjects with persistent microalbuminuria. B. M. J. 1988; 297: 1092–1095
   PubMed Web of Science ®Google Scholar
• Lewis E J, Hunsiker L G, Bain R P, Rohde R D. for the Collaborative Study Group. The effect of angiotensin converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 1993; 329: 1456–1462
   PubMed Web of Science ®Google Scholar
• Maschio G, Alberti D, Janin G, Locatelli F, Mann J FE, Motolese M, Ponticelli C, Ritz E, Ziuchelli P. ACE inhibition in Progressive Renal Insufficiency Study Group: effect of the ACE inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 1996; 334: 939–945
   PubMed Web of Science ®Google Scholar
• Costerousse O, Jaspard E, Alhenc-Gelas F. Molecular and genetic aspects of dipeptidylcarboxypeptidase I (the angiotensin I converting-enzyme). Expression in the immune system. Advances in Neuroimmunology 1993; 3: 217–224
   Google Scholar
• Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E. Expression and characterization of recombinant human angiotensin I-converting enzyme. J. Biol. Chem. 1991; 266: 5540–5546
   PubMed Web of Science ®Google Scholar
• Alhenc-Gelas F, Richard J, Courbon D, Warnet J, Corvol P. Ditribution of plasma angiotensin I-converting enzyme levels in healthy men: Relationship to environmental and hormonal parameters. J. Lab. Clin. Med. 1991; 117: 33–39
   PubMedGoogle Scholar
• Cambien F, Alhenc-Gelas F, Herberth B, Andre J, Rakotovao R, Gonzales M, Allegrini J, Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 1988; 43: 774–780
   PubMed Web of Science ®Google Scholar
• Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Treagear J, Corvol P. Two putative active centers in human angiotensin I converting-enzyme revealed by molecular cloning. Proc. Nat. Acad. Sci. USA 1988; 85: 9386–9390
   PubMed Web of Science ®Google Scholar
• Lattion A L, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F. The testicular transcript of angiotensin I-converting enzyme encodes for the ancestral, non duplicated form of the enzyme. FEBS Lett. 1989; 252: 99–104
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphysm in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343–1346
   PubMed Web of Science ®Google Scholar
• Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 1993; 290: 33–40
   PubMed Web of Science ®Google Scholar
• Doria A, Warram J H, Krolewski A S. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690–695
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucl Acid Res. 1992; 20: 1433
   PubMed Web of Science ®Google Scholar
• Ludwig E, Corneli P, Anderson J, Marshall H W, Lalouel J M, Ward R H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120–4
   PubMed Web of Science ®Google Scholar
• Marre M, Jeunemaïtre J, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller R, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. Contributions of genetic polymorphisms of the renin angiotensin system to renal complications in insulin dependant diabetes. 1996, for the Genediab Study Group. Submitted.
   Google Scholar
• Cushman D, Cheung M. Concentrations of angiotensin-converting enzyme in tissues of rat. Biochim. Biophys. Acta 1971; 65: 250–261
   Google Scholar
• Alhenc-Gelas F, Weare J, Johnson R, Erdös E. Measurements of human converting enzyme level by direct radioimmunoassay. J. Lab. Clin. Med. 1983; 101: 83–96
   PubMedGoogle Scholar
• Danilov S, Savoie F, Lenoir B, Jeunemaïtre X, Azizi M, Tarnow L, Alhenc-Gelas F. Development of enzyme linked immunoassays for human angiotensin I-converting enzyme suitable for large studies. J. of Hypert. 1996; 14: 709–717
   Google Scholar
• Cambien F, Poirier O, Lecerf L, Evans A, Cambou J P, Arveiler D, Luc G., Bard J., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641–4
   PubMed Web of Science ®Google Scholar
• Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzalez M F, Evans A, Arveiller D, Cambou J P, Luc G, Rakotovao P, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and ACE gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669–76
   PubMed Web of Science ®Google Scholar
• Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou J P, Arveiller D, Luc G., Amouyel P., Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991–2
   PubMed Web of Science ®Google Scholar
• Lindpaintner K, Pfeffer M A, Kreutz R, Stampfer M J, Grodstein F, Lamotte F, Buring T, Hennelens C I. A prospective eveluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. of Med. 1995; 333: 458–459
   Google Scholar
• Samami N J, Thompson J R, O'Toole L, Channer K, Woods K L. A meta analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708–712
   PubMed Web of Science ®Google Scholar
• Marian A J, Yu Q T, Workman R, Greve G, Roberts R. Angiotensin — converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1073–5
   PubMedGoogle Scholar
• Shunckert H, Hense H W, Holmer S R, Stender M, Perz S, Keil U, Lorell B, Riegger G. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N. Engl. J. of Med. 1994; 330: 1634–38
   PubMed Web of Science ®Google Scholar
• Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T T, Haliab M, Cambien F, Passa P, Alhenc-Gelas F. Relationship between angiotensin I-converting enzyme gene polymorphism, plasma level and diabetic retinal and renal complications. Diabetes 1994; 43: 384–388
   PubMed Web of Science ®Google Scholar
• Fogarty D G, Maxwell A P, Hughes A, Nevin N C, Doherthy C C. A deletion polymorphism in the angiotensin-converting enzyme gene is a risk factor for diabetic nephropathy. EDTA proceedings. 1994, 117
   Google Scholar
• Powrie J K, Watts G F, Ingham J N, Taub N A, Talmud P J, Shaw K M. Role of glycaemic control in development of microalbuminuria in patients with insulin-dependent diabetes. B. M. J. 1994; 309: 1608–1612
   PubMed Web of Science ®Google Scholar
• Tarnow I, Cambien F, Rossing P, Nielsen F S, Hansen B V, Lecerf L, Poirier O, Danilov S, Parving H H. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489–494
   PubMed Web of Science ®Google Scholar
• Schmidt S, Schone N, Ritz E, Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy?. Kidney Int. 1995; 47: 1176–1181
   PubMed Web of Science ®Google Scholar
• Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A. Angiotensin-converting-enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 455–459
   PubMedGoogle Scholar
• Doi Y, Yoshigumi H, Lino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M. Association between a polymorphism in the angiotensin-converting-enzyme gene and microavascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97–102
   PubMed Web of Science ®Google Scholar
• Dudley C RK, Keavney B, Stratton I M, Turner R C, Ratcliffe P J. U.K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 1995; 48: 1907–1911
   PubMed Web of Science ®Google Scholar
• Harden P N, Geddes C, Rowe P A, McLlroy J H, Boulton-Jones M, Rodger R SC, Junor B JR, Briggs J D, Connell J MC, Jardine A G. Polymorphisms in angiotensin-converting-enzyme gene and progression og IgA nephropathy. Lancet 1995; 345: 1540–1542
   PubMed Web of Science ®Google Scholar
• Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyasaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O. Role of the deletion polymorphism of the angiotensin-converting-enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Glin. Invest. 1995; 96: 2162–2169
   PubMed Web of Science ®Google Scholar
• Van Essen G G, Rensma P L, De Zeeuw D, Sluiter W J, Scheffer H, Apperloo A J, De Jong P E. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 94–95
   PubMed Web of Science ®Google Scholar
• Lachurie M L, Azizi M, Guyene T T, Alhenc-Gelas F, Menard J. Angiotensin-converting-enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91: 2933–2942
   PubMed Web of Science ®Google Scholar
• Ueda S, Elliott H L, Morton J J, Connell J M. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for a angiotensin-converting-enzyme. Hypertension 1995; 25: 1266–1269
   PubMed Web of Science ®Google Scholar
• Jeunemaïtre X, Lifton R P, Hunt S C, Williams R R, Lalouel J M. Absence of linkage between the angiotensin-converting-enzyme locus and human essential hypertension. Nature Genetics 1992; 1: 72–75
   PubMed Web of Science ®Google Scholar
• Danser A H, Koning M M, Admiraal P J, Sassen L M, Derkx F H, Verdouw P D. Production of angiotensin I and II at tissue sites intact pigs. American Journal of Physiology 1992; 263: H429–H437
   Google Scholar
• Vane G R. Sites of conversion of angiotensin I. Hypertension, J Genest, E Koine. Springer Verlag, Berlin 1972; 523–532
   Google Scholar
• Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F, Corvol P. The angiotensin I-converting enzyme in the kidney. J. Hypertens. 1989; 7: S9–S13
   Google Scholar
• Roman R J, Kaldunski M L, Scicli A G, Carretero O A. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am. J. Physiol. 1988; 255: 801–804
   Google Scholar
• Linz W, Wiemer G, Scholkens B A. Role of kinins in the pathophysiology of myocardial ischemia In vitro and in vivo studies. Diabetes 1996; 45 (Suppl.) 1: S51–S58
   Google Scholar
• Schunkert H, Dzau V J, Tang S S, Hirsh A T, Apstein C S, Lorell B H. Increased rat cardiac angiotensin enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J. Clin. Invest. 1990; 86: 1913–1920
   PubMed Web of Science ®Google Scholar
• Johnston C I. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994; 23: 258–268
   PubMed Web of Science ®Google Scholar
• Challah M, Nicoletti A, Arnal J F, Philippe M, Laboulandine I, Allegrini J, Alhenc-Gelas F, Danilov S, Michel J B. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovascular Research 1995; 30: 231–239
   PubMed Web of Science ®Google Scholar
• Arnal J F, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, Michel J B, Alhenc-Gelas F. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol. 1994; 267: H1777–H1784
   PubMed Web of Science ®Google Scholar
• Vio C P, Alhenc-Gelas F. Differential distribution of angiotensin I converting enzyme in normal and hypertensive rat kidneys. Hypertension 1995; 25: 18
   Google Scholar